Glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Previous treatment analyses from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials - 03/08/18
David Pariser, MD, Eastern Virginia Medical School and Virginia Clinical Research, Inc.; Adelaide Hebert, MD, UT Health McGovern Medical School, Houston; Alexander Nast, MD, Charité-Universitätsmedizin Berlin; William Werschler, MD, Premier Clinical Research; Stephen Shideler, MD, Shideler Dermatology and Skin Care Center; Lawrence Green, MD, George Washington University School of Medicine; Richard Mamelok, MD, Mamelok Consulting; John Quiring, PhD, QST Consultations; Janice Drew, MPH, Dermira; Dee Anna Glaser, MD, Saint Louis University
Le texte complet de cet article est disponible en PDF. Commercial support: Dermira, Inc. Medical writing support provided by Prescott Medical Communications Group, Chicago, Illinois. All costs associated with development of this abstract were funded by Dermira. |
Vol 79 - N° 3S1
P. AB147 - septembre 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?